Skip to content

Sickle Cell Children's Exercise Study (SuCCESs)

Sickle Cell Children's Exercise Study Determining the Effects of a Targeted Exercise Training Program on Neuromuscular Performance, Locomotor Efficiency, and Exercise Tolerance in Children With Sickle Cell Disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06074198
Acronym
SuCCESs
Enrollment
20
Registered
2023-10-10
Start date
2023-11-03
Completion date
2026-12-31
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

physical therapy, neuromotor performance, functional capacity

Brief summary

The Sickle Cell Children's Exercise Study (SuCCESs) will explore the feasibility and effects of a moderate intensity strengthening, balance, speed, and agility intervention program in children with sickle cell disease.

Detailed description

Participants will perform the baseline assessment and after six weeks of performing the SuCCESs program the participants will perform a post-intervention assessment. Participants will be asked to attend a total of six physical therapy in-person sessions (1x/week) at the University of Maryland Department of Physical Therapy and Rehabilitation Science and to perform 12 home program sessions.

Interventions

BEHAVIORALSuCCESs

strengthening and endurance exercises

Sponsors

University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

One physical therapist will perform the pre- and post-test assessment measures and another pediatric physical therapist will perform the intervention sessions.

Intervention model description

feasibility study

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children 6-17 years of age diagnosed with sickle cell disease

Exclusion criteria

* Diagnosis of neurological disorder, not related to sickle cell disease * Lower extremity injury such as a fracture with a cast

Design outcomes

Primary

MeasureTime frameDescription
knee extension strengthweek 1 and week 7dynamometry to measure knee extension strength
Rate of Muscle Activationweek 1 and week 7Electromyography used to measure rate of muscle activation
exercise toleranceweek 1 and week 76-Minute Walk Test used to measure exercise tolerance
locomotor efficiencyweek 1 and week 7oxygen uptake used to measure locomotor efficiency
number of sessions attendedthroughout the entire study week 1, weeks 2-6, six weeks of intervention, and week 7attendance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026